Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3026218 | Seminars in Vascular Surgery | 2011 | 5 Pages |
Abstract
Chronic hemodialysis via a tunneled dialysis catheter (TDC) is associated with a high incidence of infectious complications and increased mortality and, therefore, should only be considered when all other options for vascular access are exhausted. The Hemoaccess Reliable Outflow (HeRO) Vascular Access Device (Hemosphere, Inc., Minneapolis, MN) is an alternative to the TDC. Early results suggests that the infectious complications are significantly less for the HeRO device when compared to the TDC, and the secondary patency for the device approximates that for prosthetic accesses. The device can be successfully placed in >90% of catheter-dependent patients. Chronic hemodialysis via the HeRO Device is preferable to TDC use.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marc H. Glickman,